Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 20/1/2018
SIETES contiene 92186 citas

 
 
 1 a 20 de 247 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Bjørk M, Riedel B, Spiqset O, Veiby G, Kolstad E, Daltveit AK, Gilhus NE. Association of folic acid supplementation during pregnancy with the risk of autistic traits in children exposed to antiepileptic drugs In utero. JAMA Neurology 2017:26 de diciembre. [Ref.ID 102193]
2. Cita con resumen
Bromley RL, Weston J, Marson AG. Maternal use of antiepileptic agents during pregnancy and major congenital malformations in children. JAMA 2017;318:1700-1. [Ref.ID 102140]
3. Cita con resumen
Hesdorffer CS, Longo DL. Drug-induced megaloblastic anemia. N Engl J Med 2015;373:1649-58. [Ref.ID 99629]
4. Cita con resumen
Anónimo. Drug-induced liver injury. Australian Prescriber 2013;36:168-9. [Ref.ID 96320]
6.Tiene citas relacionadas Cita con resumen
Cantrell L, Suchard JR, Wu A, Gerona RR. Stability of active ingredients in long-expired prescription medications. Arch Intern Med 2012;172:1685-6. [Ref.ID 94268]
7.Enlace a cita original
Papay J, Yuen N, Powell G, Mockenhaupt M, Bogenrieder T. Spontaneous adverse event reports of Stevens-Johnson syndrome/toxic epidermal necrolysis: detecting associations with medications. Pharmacoepidemiol Drug Saf 2012;21:289-96. [Ref.ID 92467]
8.Tiene citas relacionadas Cita con resumen
Brodie MJ, Kwan P. Newer drugs for focal epilepsy in adults. BMJ 2012;344:49-54. [Ref.ID 92316]
9.Enlace a cita originalTiene citas relacionadas Cita con resumen
Nunes VD, Sawyer L, Neilson J, Sarri G, Cross JH. Diagnosis and management of the epilepsies in adults and children: summary of updated NICE guidance. BMJ 2012;344:47-9. [Ref.ID 92315]
10. Cita con resumen
Théophile H, Laporte JR, Moore N, Martin K-L, Bégaud B. The case-population study design: an analysis of its application in pharmacovigilance. Drug Saf 2011;34:861-8. [Ref.ID 91174]
11.Tiene citas relacionadas Cita con resumen
Anónimo. Accroissements gingivaux d'origine médicamenteuse. Prescrire 2011;31:432-3. [Ref.ID 91054]
12.Enlace a cita original
van Ommeren M, Barbui C, de Jong K, Dua T, Jones L, Perez-Sales P, Schilperoord M, Ventevogel P, Tasamy MT, Saxena S. If you could only choose five psychotropic medicines: updating the interagency emergency health kit. PLOS Medicine 2011:mayo. [Ref.ID 90733]
13. Cita con resumen
Tomson T, Battino D, Bonizzoni E, Craig J, Sabers DA, Perucca E, Vajda F, for the EURAP study group. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 2011;10:609-17. [Ref.ID 90724]
14. Cita con resumen
Karouni M, Arulthas S, Larsson PG, Rytter E, Johannessen SI, Landmark CJ. Psychiatric comorbidity in patients with epilepsy: a population-based study. Eur J Clin Pharmacol 2010;66:1151-60. [Ref.ID 89587]
15.Enlace a cita original Cita con resumen
Oteri A, Trifirò G, Gagliostro MS, Tari DU, Moretti S, Bramanti P, Spina E, Caputi AP, Arcoraci V. Prescribing pattern of anti-epileptic drugs in an Italian setting of elderly outpatients: a population-based study during 2004-07. Br J Clin Pharmacol 2010;70:514-22. [Ref.ID 89441]
18.Enlace a cita original
de la Fuente Honrubia C, García del Pozo J, de Abajo FJ. Utilización de antiepilépticos en España, 1992-2006. Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) 2009:1-9. [Ref.ID 86454]
19.Tiene citas relacionadas
Crawford PM. Managing epilepsy in women of childbearing age. Drug Saf 2009;32:293-307. [Ref.ID 85763]
20. Cita con resumen
Sloss A. Prescribing in liver disease. Australian Prescriber 2009;32:32-5. [Ref.ID 85568]
Seleccionar todas
 
 1 a 20 de 247 siguiente >>